Skip to main content

Table 4 The serial change in mean value (SD) of uroflowmetric parameters

From: Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Variable

Baseline

1 month

3 months

6 months

12 months

Uroflowmetric parameters

    

Vioded Vol.(mL)

    

Naftopidil (n=70)

260 (129)

153** (95)

141** (72)

155** (72)

185** (128)

Silodosin (n=71)

209 (111)

151** (89)

128** (81)

144** (76)

172** (100)

Total (n=141)

236 (123)

152** (92)

135** (77)

150** (74)

178** (115)

Qmax (mL/s)

Naftopidil (n=70)

13.2 (6.0)

9.7** (4.4)

8.8** (3.8)

8.9** (3.3)

11.4** (5.4)

Silodosin (n=71)

12.1 (5.2)

9.4** (4.5)

8.7** (4.4)

9.5** (4.6)

11.0** (5.4)

Total (n=141)

12.6 (5.7)

9.6** (4.4)

8.7** (4.1)

9.2** (4.0)

11.2** (5.4)

PVR (mL)

Naftopidil (n=70)

19 (38)

36** (45)

32** (39)

34** (38)

25 (36)

Silodosin (n=71)

23 (27)

38** (36)

52** (71)

37** (34)

35* (45)

Total (n=141)

21 (34)

37** (41)

42** (58)

35** (36)

30* (41)

  1. *p < 0.05, **p < 0.01.